Pharmacokinetic profiles were obtained for 16 heart or lung recipients following the administration of identical doses of cyclosporin as oral solution and capsules on consecutive days. A comparison of pharmacokinetic parameters (AUC, Cmax, Cmi n and tmax) showed that there were no significant differ
Subcutaneous injection of oral cyclosporin A solution
β Scribed by Rajiv Midha; Susan E. Mackinnon; Peter J. Evans; Timothy J. Best; P. Y. Wong
- Book ID
- 102508744
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 265 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0738-1085
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Cyclosporin A (CyA) is the agent of choice for immunesuppression in the majority of rodent organ and tissue allotransplantation experiments. Subcutaneous injection of suitably dissolved pure CyA powder preparation is the acceptable standard of drug administration. We investigated the possibility of using oral CyA solution in an injectable form and compared its availability with that of the standard solution in a rat model. Oral CyA solution diluted in placebo (olive oil) and standard solution prepared from pure compound were injected subcutaneously at a dose of 5 mg/kg/day to two groups of rats. Trough whole blood CyA concentrations were measured on day 10 following initiation of treatment. Blood CyA levels of the standard solution group (1,167 Β± 246 ΞΌg/liter, mean Β± SD) were virtually identical to those of the oral solution group (1,105 Β± 179 ΞΌg/liter; P > 0.05). In addition, the oral solution was easier to prepare and caused less injection site morbidity than the standard solution. We conclude that placeboβdiluted oral CyA solution may be safely injected subcutaneously to rats and results in consistent blood levels, comparable to those achieved with standard solution prepared from pure compound. Β© WileyβLiss, Inc.
π SIMILAR VOLUMES
Recently cyclosporin A (CsA) capsules have been introduced to meet a number of disadvantages associated with the use of the oral solution. We compared the pharmacokinetics of the oral solution and the capsules in a group of nine renal transplant patients during the first 3 weeks after transplantatio
The intestinal lymphatic absorption of cyclosporin A (CyA) following oral adminstration of 6.5 f0.6 and 252f 1.4mg kg-' doses of the drug dissolved in an olive oil solution was studied using a thoracic duct-cannulated rat model. Cumulative lymph samples were collected for up to 114h post-dosing and